Testing effectiveness (Phase 2)UnknownNCT00003253What this trial is testingEvaluation of Drug Resistance in Patients With Metastatic Breast CancerWho this might be right forBreast Cancer Oncotech 100
Early research (Phase 1)Active Not RecruitingNCT04704661What this trial is testingTesting the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialWho this might be right forAdvanced Breast CarcinomaAdvanced Colon CarcinomaAdvanced Colorectal Carcinoma+37 more National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Ended earlyNCT00045591What this trial is testingCelecoxib in Treating Women With Metastatic or Recurrent Breast CancerWho this might be right forBreast Cancer Alliance for Clinical Trials in Oncology 39
Large-scale testing (Phase 3)UnknownNCT00326820What this trial is testingIbandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast CancerWho this might be right forBreast CancerHypercalcemia of MalignancyMetastatic Cancer Wales Cancer Trials Unit 1,404
Testing effectiveness (Phase 2)Active Not RecruitingNCT05751668What this trial is testingFinding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)Who this might be right forAnatomic Stage IV Breast Cancer AJCC v8Chemotherapy-Induced Peripheral NeuropathyMetastatic Breast Carcinoma Alliance for Clinical Trials in Oncology 7
Testing effectiveness (Phase 2)Study completedNCT00055861What this trial is testingBevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast CancerWho this might be right forRecurrent Breast CancerStage IV Breast Cancer National Cancer Institute (NCI) 27
Early research (Phase 1)Looking for participantsNCT04150042What this trial is testingSHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem CellsWho this might be right forPancreatic Adenocarcinoma MetastaticBRCA1 MutationBRCA2 Mutation+17 more General Oncology, Inc. 24
Very early researchStudy completedNCT01730729What this trial is testingCabergoline in Metastatic Breast CancerWho this might be right forRecurrent Breast CancerStage IV Breast Cancer Northwestern University 20
Testing effectiveness (Phase 2)Study completedNCT03326102What this trial is testingOral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast CancerWho this might be right forRecurrent or Metastatic Breast Cancer Daehwa Pharmaceutical Co., Ltd. 72
Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00019812What this trial is testingMonoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2Who this might be right forBreast Cancer National Institutes of Health Clinical Center (CC) 55
Testing effectiveness (Phase 2)Study completedNCT00006381What this trial is testingCelecoxib and Trastuzumab in Treating Women With Metastatic Breast CancerWho this might be right forBreast Cancer Memorial Sloan Kettering Cancer Center
Not applicableActive Not RecruitingNCT04314401What this trial is testingNational Cancer Institute "Cancer Moonshot Biobank"Who this might be right forAcute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more National Cancer Institute (NCI) 1,600
Testing effectiveness (Phase 2)Study completedNCT02614794What this trial is testingTucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast CancerWho this might be right forHER2 Positive Breast Cancer Seagen Inc. 612
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Not applicableStudy completedNCT00079170What this trial is testingDocetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00003761What this trial is testingVaccine Therapy in Treating Patients With Metastatic Breast CancerWho this might be right forBreast Cancer Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12
Large-scale testing (Phase 3)UnknownNCT05670054What this trial is testingCyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer PatientsWho this might be right forBreast Cancer Stage IV Mansoura University 116
Early research (Phase 1)Study completedNCT00003927What this trial is testingCombination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast CancerWho this might be right forBreast Cancer City of Hope Medical Center 15